ANDA Submissions Continue Yo-Yo Pattern, Unlike Approvals
After spike in March, generic drug application submissions drop 62% in April, while approval volume remains at monthly average.

After spike in March, generic drug application submissions drop 62% in April, while approval volume remains at monthly average.